S&P 500   3,752.47 (-1.76%)
DOW   30,784.83 (-1.55%)
QQQ   302.30 (-2.22%)
AAPL   119.47 (-2.12%)
MSFT   225.59 (-0.87%)
FB   255.44 (+0.01%)
GOOGL   2,031.24 (+0.99%)
TSLA   608.00 (-6.92%)
AMZN   2,961.01 (-1.46%)
NVDA   488.69 (-4.59%)
BABA   229.82 (-2.73%)
CGC   30.70 (-7.64%)
GE   13.32 (-0.89%)
MU   83.07 (-6.78%)
NIO   38.54 (-7.20%)
AMD   77.52 (-4.13%)
T   28.81 (+0.31%)
F   11.76 (-3.37%)
ACB   9.65 (-7.74%)
DIS   185.28 (-3.63%)
BA   221.65 (-3.02%)
NFLX   511.77 (-1.71%)
PFE   34.00 (-1.13%)
S&P 500   3,752.47 (-1.76%)
DOW   30,784.83 (-1.55%)
QQQ   302.30 (-2.22%)
AAPL   119.47 (-2.12%)
MSFT   225.59 (-0.87%)
FB   255.44 (+0.01%)
GOOGL   2,031.24 (+0.99%)
TSLA   608.00 (-6.92%)
AMZN   2,961.01 (-1.46%)
NVDA   488.69 (-4.59%)
BABA   229.82 (-2.73%)
CGC   30.70 (-7.64%)
GE   13.32 (-0.89%)
MU   83.07 (-6.78%)
NIO   38.54 (-7.20%)
AMD   77.52 (-4.13%)
T   28.81 (+0.31%)
F   11.76 (-3.37%)
ACB   9.65 (-7.74%)
DIS   185.28 (-3.63%)
BA   221.65 (-3.02%)
NFLX   511.77 (-1.71%)
PFE   34.00 (-1.13%)
S&P 500   3,752.47 (-1.76%)
DOW   30,784.83 (-1.55%)
QQQ   302.30 (-2.22%)
AAPL   119.47 (-2.12%)
MSFT   225.59 (-0.87%)
FB   255.44 (+0.01%)
GOOGL   2,031.24 (+0.99%)
TSLA   608.00 (-6.92%)
AMZN   2,961.01 (-1.46%)
NVDA   488.69 (-4.59%)
BABA   229.82 (-2.73%)
CGC   30.70 (-7.64%)
GE   13.32 (-0.89%)
MU   83.07 (-6.78%)
NIO   38.54 (-7.20%)
AMD   77.52 (-4.13%)
T   28.81 (+0.31%)
F   11.76 (-3.37%)
ACB   9.65 (-7.74%)
DIS   185.28 (-3.63%)
BA   221.65 (-3.02%)
NFLX   511.77 (-1.71%)
PFE   34.00 (-1.13%)
S&P 500   3,752.47 (-1.76%)
DOW   30,784.83 (-1.55%)
QQQ   302.30 (-2.22%)
AAPL   119.47 (-2.12%)
MSFT   225.59 (-0.87%)
FB   255.44 (+0.01%)
GOOGL   2,031.24 (+0.99%)
TSLA   608.00 (-6.92%)
AMZN   2,961.01 (-1.46%)
NVDA   488.69 (-4.59%)
BABA   229.82 (-2.73%)
CGC   30.70 (-7.64%)
GE   13.32 (-0.89%)
MU   83.07 (-6.78%)
NIO   38.54 (-7.20%)
AMD   77.52 (-4.13%)
T   28.81 (+0.31%)
F   11.76 (-3.37%)
ACB   9.65 (-7.74%)
DIS   185.28 (-3.63%)
BA   221.65 (-3.02%)
NFLX   511.77 (-1.71%)
PFE   34.00 (-1.13%)
Log in
OTCMKTS:PRLX

Parallax Health Sciences Stock Forecast, Price & News

$0.01
0.00 (0.00 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.02
52-Week Range
$0.00
Now: $0.01
$0.10
VolumeN/A
Average Volume29,374 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Parallax Health Sciences, Inc. builds and expands an integrated digital healthcare network with products and services that provide remote communication, diagnosis, treatment, and monitoring of patients. The company offers remote healthcare products, including patent pending software and mobile apps, and other services, as well as electronic kits and devices from third-party licensed platforms that are designated towards a patient's primary health concern, such as diabetes, blood pressure, cardiovascular, general monitoring, etc.; and audio and video options that interface with the patient's healthcare providers. It also provides prescription medication dosage monitoring services; and behavioral health products comprising REBOOT, a proprietary behavioral health technology for an individual or an organization to transform the cost of treating and managing chronic illnesses that include pulmonary-COPD-asthma, diabetes, and cardiovascular diseases by effecting the modification of behavior in patients being treated for these chronic diseases. In addition, the company offers diagnostics products, which comprise Target System, a proprietary POC diagnostic immunoassay testing platform; and test cartridges for the areas of infectious diseases, cardiac markers, drugs of abuse, and various other medical conditions, as well as VT-1000 desktop analyzers, target antigen detection systems, and other products. Further, it provides SPARKS Mobile, a target system hand-held analyzer; COMPASS for behavioral modification; Fotodigm platform for remote patient monitoring, telehealth, and POC diagnostic testing services; and Intrinsic Code technology for actionable insights to behavior modification. The company was formerly known as Endeavor Power Corporation and changed its name to Parallax Health Sciences, Inc. in January 2014. Parallax Health Sciences, Inc. was founded in 2005 and is headquartered in Santa Monica, California.

Headlines

A vision realized
February 14, 2021 |  msn.com
More Than Meets The AudioEye - Risks Outweigh The Bull Case
September 15, 2020 |  seekingalpha.com
Parallax Health Sciences Inc
July 30, 2020 |  www.bloomberg.com
Parallax Health Sciences Inc.
June 17, 2020 |  www.marketwatch.com
Parallax Announces International Medical Supply...
March 30, 2020 |  www.benzinga.com
Healthcare firms announce Covid-19-related actions
March 23, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PRLX
CUSIPN/A
Phone+1-310-8994442
Employees9
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.54 out of 5 stars

Medical Sector

1444th out of 1,969 stocks

Diagnostics & Research Industry

9th out of 13 stocks

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.01
0.00 (0.00 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PRLX News and Ratings via Email

Sign-up to receive the latest news and ratings for PRLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Parallax Health Sciences (OTCMKTS:PRLX) Frequently Asked Questions

What stocks does MarketBeat like better than Parallax Health Sciences?

Wall Street analysts have given Parallax Health Sciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Parallax Health Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Parallax Health Sciences' stock price been impacted by COVID-19 (Coronavirus)?

Parallax Health Sciences' stock was trading at $0.0790 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PRLX shares have decreased by 86.1% and is now trading at $0.0110.
View which stocks have been most impacted by COVID-19
.

Who are Parallax Health Sciences' key executives?

Parallax Health Sciences' management team includes the following people:
  • Mr. Paul R. Arena, CEO & Chairman (Age 62, Pay $567.82k)
  • Ms. Calli R. Bucci, CFO, Corp. Sec. & Director (Age 56, Pay $267.36k)
  • Mr. Nathaniel T. Bradley, CTO & Director (Age 44, Pay $227.66k)
  • Dr. David L. Stark, Pres (Age 63)

Who are some of Parallax Health Sciences' key competitors?

What other stocks do shareholders of Parallax Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Parallax Health Sciences investors own include Broadcom (AVGO), Baidu (BIDU), Catalyst Biosciences (CBIO), Celsion (CLSN), DocuSign (DOCU), Shopify (SHOP), Tilray (TLRY), Workhorse Group (WKHS), American Airlines Group (AAL) and AbbVie (ABBV).

What is Parallax Health Sciences' stock symbol?

Parallax Health Sciences trades on the OTCMKTS under the ticker symbol "PRLX."

How do I buy shares of Parallax Health Sciences?

Shares of PRLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Parallax Health Sciences' stock price today?

One share of PRLX stock can currently be purchased for approximately $0.01.

How many employees does Parallax Health Sciences have?

Parallax Health Sciences employs 9 workers across the globe.

What is Parallax Health Sciences' official website?

The official website for Parallax Health Sciences is www.parallaxhealthsciences.com.

Where are Parallax Health Sciences' headquarters?

Parallax Health Sciences is headquartered at 1327 Ocean Ave Ste M, SANTA MONICA, CA 90401-1033, United States.

How can I contact Parallax Health Sciences?

Parallax Health Sciences' mailing address is 1327 Ocean Ave Ste M, SANTA MONICA, CA 90401-1033, United States. The company can be reached via phone at +1-310-8994442.


This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.